DecreaseText Size Reset Text Size Increase Text Size
 
resize Print E-mail
Search
News
24/02/2011
The 10th Pan-Hellenic Conference of Pharma PLUS was held in Karditsa recently, where more than 90 attendees - members of the network participated. Today, the Pharma PLUS network lists 88 pharmacies, which in 2010 marked an increase in sales of 14.4% in nutritional supplements and 4.5% in parapharmaceuticals. They also had significantly better results in the prescription sector compared to the rest of the market that declined by 12.6% due to the decrease of their prices.
International Activity
Since 1984, Lavipharm Group has embarked on an international course. France was the first "stop" followed by the USA. The Group's activities focus on research as well as international marketing.

It is designed on two strategies: the worldwide promotion and marketing of existing pharmaceutical and skincare products developed in its in-house R&D facilities and the application of Lavipharm's innovative technologies for the development of products on behalf of other major pharmaceutical companies worldwide.

The Group collaborates with multinational companies in order to hold a leading position in the international pharmaceutical market with well-known products, developing simultaneously the difficult but essential Research & Development sector. Lavipharm’s international co operations are with 3M, Abbott Laboratories, Crinos, Dava, Ethypharm, Ferrer, GlaxosmithKline, Helsinn, Kullgren Pharma, Mundipharma, Novartis, Paladin, Pfizer, Pohl Boskamp, Sanofi Aventis, Se-Cure Pharmaceuticals, So.Se. Pharm.

Lavipharm’s international presence is in: Albania, Belgium, Canada, China, Cyprus, France, Germany, Greece, Hong-Kong, Italy, Jordan, Kuwait, Lebanon, Libya, Morocco, Martinique, Mauritius, Qatar, South Arabia, South Korea, Spain, Taiwan, Tunisia, U.S.A..
 





Copyright© 2011 Lavipharm. All Rights Reserved | Legal Restrictions & Terms of use | Privacy Policy